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HORMONES – CYTOKINES – SIGNALING
Protein kinase CK2 mediates TGF-b1-stimulated type IV
collagen gene transcription and its reversal by estradiol1
MIROSLAW ZDUNEK, SHARON SILBIGER, JUN LEI, and JOEL NEUGARTEN
Nephrology Division, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx,
New York, USA
Protein kinase CK2 mediates TGF-1-stimulated type IV col- rate of deterioration of renal function in non-diabetic
lagen gene transcription and its reversal by estradiol. renal disease using 68 studies that contained a total of
Background. We have previously shown that the transcrip- 11,345 patients [3]. The results indicated that men withtion factor Sp1 mediates the stimulatory effects of transforming
chronic renal failure due to IgA nephropathy, membra-growth factor-1 (TGF-1) on type IV collagen gene transcrip-
nous nephropathy, polycystic kidney disease or unspeci-tion and protein synthesis, and that estradiol reverses these
effects by down-regulating Sp1 activity. Protein kinase casein fied chronic renal disease show a more rapid decline in
kinase II (CK2) phosphorylates Egr-1 and prevents its binding renal function with time than do women [3]. Sex hor-
to Sp1. We hypothesized that TGF-1 stimulates CK2 activity, mones may directly influence many of the processes im-which in turn activates type IV collagen gene transcription via
plicated in renal disease progression, including mesangialincreased availability of free Sp1.
Methods. The effects of TGF-1 and of estradiol on murine cell matrix synthesis and degradation, as well as the syn-
mesangial cell type IV collagen gene transcription were mea- thesis and release of various cytokines, vasoactive agents
sured using a reporter mini gene construct and on collagen IV and growth factors [1, 2]. In animal models of renal
protein synthesis by Western blotting. Nuclear Egr-1, phos-
disease, manipulation of the hormonal milieu by glandphorylated Egr-1, Sp1, Egr-1/Sp1 complexes and unbound Sp1
ablation or by the administration of exogenous sex hor-were measured using co-immunoprecipitation and Western
blotting techniques. mones replicates the effects of gender on the course of
Results. TGF-1 stimulated CK2 activity in murine mesan- chronic renal disease [1, 2]. These data suggest the impact
gial cells. Although TGF-1 failed to alter total Egr-1 protein, of gender on renal disease progression may reflect recep-it increased phosphorylated Egr-1. This led to decreased Egr-1/
tor-mediated direct effects of sex hormones [1, 2].Sp1 complex formation, increased unbound Sp1, increased bind-
We previously observed that estradiol suppressed typeing of nuclear extracts to the collagen IV promoter, and increased
type IV collagen gene transcription and protein synthesis. Physi- IV collagen synthesis by mesangial cells when they were
ologic concentrations of estradiol reversed these effects. grown in the presence of serum whereas estradiol had
Conclusions. These studies suggest that activation of CK2
no effect in serum-free medium [4, 5]. Our subsequentmediates the stimulatory effect of TGF-1 on type IV collagen
study showed that serum increased mesangial cell colla-gene transcription. Moreover, the ability of estradiol to reverse
TGF-1-stimulated type IV collagen synthesis is mediated by gen IV synthesis by stimulating the autocrine production
down-regulating CK2 activity, which ultimately limits the avail- of transforming growth factor-1 (TFG-1) [5, 6]. More-
ability of unbound Sp1 to activate gene transcription. over, the ability of estradiol to reverse serum-stimulated
type IV collagen synthesis was mediated by its ability to
antagonize the effects of TGF-1 [5, 6]. In other studies,
We have previously suggested that gender exerts a we found that the transcription factor Sp1 mediates the
major impact on the rate of progression of chronic renal
stimulatory effect of TGF-1 on mesangial cell type IV
disease [1, 2]. To examine this hypothesis, we performed
collagen gene transcription and protein synthesis, anda meta-analysis examining the effect of gender on the
that estradiol reverses these effects by interfering with
TGF-1/Sp1 interactions [6]. Since TGF-1 is the major
1 See Editorial by Schnaper, Poncelet, and Hayashida, p. 2415. mediator of the glomerulosclerosis that underlies pro-
gressive renal injury, we hypothesized that interactionsKey words: mesangial cells, Sp1, Egr-1, gender, estrogen, sex, progres-
sive renal disease. between estradiol and TGF-1 may contribute to the
protective effect of female gender on the progression ofReceived for publication October 9, 2000
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otic cells [7, 8]. CK2 is composed of two catalytic  collected and stored at70C. The protein concentration
of all samples was measured by colorimetric assay (Bio-subunits and two regulatory subunits and can use either
adenosine 5-triphosphate (ATP) or guanine 5-triphos- Rad, Hercules, CA, USA) prior to freezing.
phate (GTP) as a phosphate donor [7, 8]. CK2 is activated
Casein kinase II activityduring cell division, cellular differentiation and em-
bryogenesis, and plays an important role in transducing Casein kinase II activity was measured in total cellular
extracts according to the method of Heller-Harrison andsignals between extracellular growth factors and nuclear
responses [7, 8]. The precise mechanisms whereby CK2 Czech [11]. Cells were washed with ice-cold PBS and
scraped using a rubber policeman into a buffer solutionis regulated in vivo are unknown. Recently, estradiol has
been shown to regulate CK2 activity [9]. The present containing 80 mmol/L -glycerophosphate, 20 mM eg-
tazic acid (EGTA), 15 mmol/L MgCl2, 50 mmol/L NaF,study was undertaken to examine the hypothesis that
estradiol and TGF-1 interact at the level of CK2 to 100 mmol/L NaVO4, 0.1 mmol/L PMSF, 10g/mL aproti-
nin, pH 7.3. The solution was lysed by drawing throughregulate the amount of free Sp1 available to drive type
IV collagen gene transcription. a 22 gauge needle 20 times and then centrifuged at
22,000  g for 20 minutes. Thirty micrograms of protein
was assayed at 30C in 20 L of assay buffer containing
METHODS
100 mmol/L Tris-HCl, pH 8.0, 100 mmol/L NaCl, 50
Isolation and characterization of murine mmol/L KCl, 20 mmol/L MgCl2, 100 mol/L NaVO4,
mesangial cells 1 mmol/L RRREEETEEE (Alexis Biochemicals, San
Diego, CA, USA), a specific substrate for CK2 [12], andMesangial cells were isolated from kidneys of 8- to
10-week-old naive SJL/J (H-2S) mice by differential glo- 20 mol/L [-32P] ATP (Amersham Pharmacia BioTech,
Piscataway, NJ, USA). Reactions were terminated aftermerular sieving. The present studies were performed on
a well-characterized, immortalized, differentiated mu- ten minutes by the addition of 0.01 mol/L ATP and
0.4 N HCl. After trichloroacetic acid precipitation, therine mesangial cell line transformed with non-replicating,
non-capsid forming SV40 virus (strain Rh 911) [10]. To precipitates were incubated on ice for five minutes and
12.5 L was spotted onto 1.5 cm2 pieces of Whatmanexclude the possibility that our results were influenced
by SV40 transformation per se, collagen synthesis experi- p81 paper. The paper was washed with 0.5% H2PO4 and
counted in a liquid scintillation counter. Counts obtainedments were reproduced in non-transformed male murine
mesangial cells. Since identical results were obtained in in control reactions run without cells were subtracted as
background. The effects of the following agents on CK2transformed and non-transformed cells, data were com-
bined. activity were assessed: TGF-1 (2 ng/mL; R & D Sys-
tems, Minneapolis, MN, USA), 5,6-dichloro-1--D-ribo-
Preparation of cytosolic and nuclear cell extracts furanosylbenzimidazole (DRB; 6 mol/L; Calbiochem,
San Diego, CA, USA), heparin (10 g/mL; Sigma), es-Mesangial cells were scraped into phosphate-buffered
saline (PBS), washed twice with PBS and pelleted by tradiol (109 mol/L; Sigma), ICI 182,780 (108 mol/L;
Tocris Cookson, Ballwin, MO, USA) polylysine (10 g/centrifuging at 3000  g for ten minutes at 4C. The
cells were resuspended in 5 volumes of hypotonic buf- mL; Sigma), alkaline phosphatase (from bovine intesti-
nal mu-cosa, 2,000 to 4,000 DEA units per mg enzymefer [10 mmol/L HEPES, pH 7.9, 1.5 mmol/L MgCl2,
10 mmol/L KCl, 0.5 mmol/L phenylmethylsulfonyl flu- protein; (0.5 to 1.5 U/mL; Sigma), sodium orthovanadate
(0.1 mmol/L; Sigma), nonradioactive GTP (10 mol/L;oride (PMSF), 0.5 mmol/L dithiothreitol (DTT); all
chemical reagents from Sigma Chemical Co., St. Louis, Sigma), staurosporine (1 mol/L; Sigma) and cyclohexi-
mide (10 g/mL; Sigma).MO, USA] and allowed to swell for ten minutes on ice.
The cells were recentrifuged at 250  g for ten minutes
Electrophoretic mobility shift assayand resuspended in 3 volumes of the hypotonic buffer
to which NP-40 was added to a final concentration of Four micrograms of nuclear extract was mixed with 20g
of poly (dI:dC) in 20 L of a reaction buffer consisting of0.05%. The cells were then homogenized in a glass
Dounce homogenizer and recentrifuged at 250  g for 25 mmol/L HEPES, pH 7.5, 1.2 mmol/L DTT, 4 mmol/L
MgCl2, 150 mmol/L NaCl, 5% glycerol, 0.005% brom-ten minutes. The supernatant was stored at 70C. The
nuclear pellet was resuspended in 50 mmol/L Tris, pH phenol blue and 0.05% Nonidet P-40 (Sigma) [13]. The
mixture was incubated on ice for 15 minutes, followed7.5, 150 mmol/L NaCl, 2 mmol/L ethylenediaminetetra-
acetic acid (EDTA), 1% Triton X-100, 0.5% deoxycho- by addition of 10 fmol of -32P (Amersham) end-labeled
oligodeoxynucleotide containing the first 60 base pairslate, 1 mmol/L PMSF, 1 g/mL aprotinin, 0.5 g/mL
leupeptin, and 0.7 mg/mL pepstatin, and incubated on of the collagen type IV promoter, relative to the 2 (IV)
transcription start site (Life Technologies, Baltimore,ice for ten minutes. The suspension was centrifuged at
20,000  g for 20 minutes at 4C. The supernatant was MD, USA) or -32P end-labeled Sp1 consensus binding
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sequence oligonucleotide (Promega, Madison, WI, USA; New protein synthesis
nucleotide sequence: 5-ATT CGA TCG GGG CGG New protein synthesis was quantitated by measuring
GGC GAG C-3). Incubation was continued for 30 min- incorporation of L-[3-H3] serine (Amersham) into cellu-
utes. The incubation mixture was subjected to electro- lar protein over a four hour period using previously de-
phoresis on a 6% polyacrylamide gel in Tris-glycine scribed techniques [4].
buffer. The gels were dried and autoradiography per-
formed at70C with an intensifying screen. Bands were Western blotting
quantitated by laser densitometry (Molecular Dynamics, Western blotting was performed to measure type IV
model 300S). Competition experiments were performed collagen synthesized by mesangial cells grown in phenol
with a 200-fold excess of unlabeled Sp1 consensus bind- red-free, serum-free RPMI. Media was collected and con-
ing sequence oligonucleotide. Supershift assays were centrated to an identical final volume using an Amicon
performed by preincubating nuclear extracts with anti- Centriprep-10 concentrator (Grace and Co., Beverly, MA,
Sp1 antibody (Santa Cruz) for 0.5 hours prior to the USA). Protein content was measured in a 0.1 mL ali-
binding reaction. quot of the concentrated media. To prepare the samples
for sodium dodecyl sulfate-polyacrylamide gel electro-Construction of reporter gene plasmids
phoresis (SDS-PAGE), 1 mL of 10% trichloroacetic acid
A plasmid containing portions of the gene encoding was added to 4 mg protein of concentrated media and
murine 1(IV) collagen was linked to luciferase coding the final volume brought to 2 mL with distilled water.
sequences to form a reporter construct HB35 as pre- The sample was vortexed and then centrifuged at 2000
viously described [14]. rpm for ten minutes. The pellet was dissolved in 1 mL
of loading buffer (2% SDS, 10% glycerol, 50 mmol/LStable transfection
Tris, 3% bromophenol blue, 2% b-mercaptoethanol,
Murine mesangial cells were cotransfected with HB35 pH 7.6), boiled for five minutes, then immediately placed
and a selection plasmid pSV2-Neo encoding for neomy-
on ice. Twenty-five, 50, 75 or 100 mg of sample was
cin-resistance at a molar ratio of 10:1 using the CaPO4- loaded for electrophoretic separation of proteins. SDS-DNA precipitation procedure [15]. Cells were then grown
PAGE was performed by standard techniques and pro-in selection medium containing Geneticin (G-418). Cells
teins transferred to a polyvinylidene difluoride (PVDF)surviving in medium with Geneticin were expanded and
microporous membrane. Anti-bovine type IV collagenreselected with the neomycin analog. Stable transfec-
antibody (Southern Biotechnology, Birmingham, AL,tants exhibited patterns of growth behavior and protein
USA) was used to detect type IV collagen.synthesis similar to the parent cell line [14].
Western blotting was performed on mesangial cell nu-
clear extracts using rabbit anti-human Egr-1 antibodyLuciferase assay
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) andCells were plated in six-well plates and grown in phe-
rabbit anti-rat Sp1 antibody to detect total Egr-1 andnol red-free, serum-free RPMI in the presence of the
total Sp1 protein, respectively. Western blots were alsoindicated agents. Cells were washed twice with PBS and
performed on protein immunoprecipitated by anti-Egr-1then lysed with 100 L Reporter Lysis Buffer (Promega)
antibody (Santa Cruz) using monoclonal anti-phospho-at room temperature for 15 minutes. Wells were then
serine antibody (Sigma) to detect the presence of phos-scraped and the cell lysate transferred to a microcen-
phorylated Egr-1. Western blots also were performedtrifuge tube and placed on ice. Tubes were vortexed and
on protein immunoprecipitated by anti-Egr-1 antibodymicrocentrifuged for two minutes at 4C. The suspen-
using anti-Sp1 antibody (Santa Cruz) to detect the pres-sion was transferred to a new microcentrifuge tube and
ence of Sp1 in the Egr-1/Sp1 protein complex. Con-stored at 70C until assayed. Twenty microliters of cell
versely, Western blots were performed on protein immu-extract was mixed with 10 L of assay reagent [20
noprecipitated by anti-Sp1 antibody using anti-Egr-1mmol/L tricine, 1.07 mmol/L (MgCO3)4 Mg(OH)2 · 5H2O,
antibody to detect the presence of Egr-1 in the Sp1/Egr-12.67 mmol/L MgSO4, 0.1 mmol/L EDTA, 33.3 mmol/L
protein complex. To determine the amount of Sp1 notDTT, 270 mol/L coenzyme A, 470 mol/L luciferin,
bound to Egr-1, nuclear extracts were first immunopre-530 mol/L ATP, pH 7.8] at room temperature. Light
cipitated with anti-Egr-1 antibody. The resultant super-emission was measured directly at room temperature
natant was then immunoprecipitated with anti-Sp1 anti-over a ten second period in a luminometer (Promega).
body and the precipitant probed by Western blottingBlank reactions were determined with equivalent vol-
with anti-Sp1 antibody.umes of lysis buffer substituted for cell lysates, and these
After blotting, the membrane was immediately placedvalues were subtracted from experimental values. Luci-
into blocking buffer (2% bovine serum albumin in washferase activity was expressed per milligram of cellular
protein in the supernatant. buffer (10 mmol/L Tris, 100 mmol/L NaCl, 0.l% Tween
Zdunek et al: Casein kinase II, TGF-b1 and estradiol2100
20) on a shaking apparatus for 30 minutes at 37C. The latory effects of FBS and of TGF-1 on CK2 activity
were not additive. TGF-1-stimulated CK2 activity wasmembrane was next washed for 30 minutes with agita-
tion. The membrane was then placed in 5% non-fat milk partly inhibited by estradiol (109 mol/L). The effect of
estradiol was reversed by ICI 182,780, a selective es-in wash buffer containing the appropriate secondary an-
tibody conjugated to horseradish peroxidase (Sigma). trogen receptor antagonist. TGF-1-stimulated CK2 ac-
tivity also was partly reversed by the selective CK2 in-The antibody conjugate was allowed to incubate for 30
minutes at 37C with agitation. After washing, the mem- hibitor, DRB.
We next determined the time course of TGF-1-stimu-brane was treated with enhanced chemiluminescence re-
agent (Amersham Life Science, Arlington Heights, IL, lated CK2 activity (Fig. 1C). Activity rose rapidly within
ten minutes after exposure to TGF-1 (2 ng/mL) withUSA) according to the manufacturer’s instructions. Ko-
dak X-OMAT 4R film (Eastman Kodak, Rochester, NY, a more gradual increase between 10 and 480 minutes,
reaching a plateau afterwards.USA) was exposed to the blot for ten minutes. Bands
were quantitated by laser densitometry. Membranes The early (4 hour) rise in CK2 activity induced by
20% FBS and by TGF-1 (2 ng/mL) was not dependentwere then washed and reprobed with monoclonal anti-
body directed against -actin (Sigma). on new protein synthesis (Table 1B). Although cyclohex-
imide (10g/mL, 4 hours) reduced new protein synthesisWe determined that the amount of protein loaded into
each lane was within the linear range of detection by by 83% (4363 	 528 vs. 720 	 6 cpm, P 
 0.001), it
failed to prevent the increase in CK2 activity observedWestern blotting in our system. All Western blotting data
were expressed as a percent of control values obtained in after four hours of exposure to 20% FBS or to TGF-1.
In addition, cycloheximide did not alter the ability ofcells grown in serum-free, phenol red-free RPMI, after cor-
recting for differences in protein loading using -actin. estradiol to reverse the effects of 20% FBS or of TGF-1
on CK2 activity at four hours. Neither cycloheximideNegative controls using irrelevant antibodies and posi-
tive controls were also performed as indicated. alone nor estradiol alone had any effect on CK2 activity
at four hours.
Statistics In contrast, the late (8 hour) increase in CK2 activity
induced by TGF-1 was dependent on new protein syn-For each individual data point, the mean of at least
five experiments was calculated. The data are means 	 thesis (Table 1B). Cycloheximide reversed TGF-1–
stimulated CK2 activity at eight hours, whereas cyclohex-SEM. Differences among groups were tested by analysis
of variance with Scheffe’s correction. P 
 0.05 was con- imide alone had no effect on basal activity. In all studies,
cell viability90% was confirmed by Trypan blue exclu-sidered a significant difference.
sion and visual inspection.
Activation of CK2 activity by TGF-1 (2 ng/mL, 4 hours)
RESULTS
was entirely localized to the nucleus. Similarly, 20% FBS
CK2 protein synthesis (4 hours) stimulated CK2 activity in nuclear but not
cytosolic fractions (Table 1C).Transforming growth factor-1 (2 ng/mL, 8 hours),
increased CK2  protein. This effect was reversed by Confirming the specificity of our in-vitro CK2 activity
assay, cold GTP inhibited the ability of TGF-1 to stimu-estradiol (Fig. 1A).
late phosphorylation of the test substrate with radiola-
CK activity beled ATP (Table 1D and Fig. 1D).
Alkaline phosphatase inhibited the activation of CK2Casein kinase II activity was low in whole cell extracts
from mesangial cells grown in serum-free, phenol red-free by TGF-1 in a dose-dependent manner (Table 1E and
Fig. 1D). The inhibitory effect of alkaline phosphataseRPMI (Table 1A and Fig. 1B). Cells were incubated with
the indicated agents for four hours and CK2 activity de- (1.5 U/mL) on TGF-1–stimulated CK2 activity was re-
versed by sodium orthovanadate. Sodium orthovanadatetermined. CK2 activity was markedly enhanced four hours
after the addition of 20% FBS to the media. Neutralizing itself had no effect on TGF-1–stimulated CK2 activity.
Neither sodium orthovanadate alone nor alkaline phos-antibody to TGF-1 partly reversed the stimulatory effect
of 20% FBS. IgG lacking anti-TGF-1 activity had no sig- phatase alone, nor the combination had any effect on
CK2 activity.nificant effect on FBS-stimulated CK2 activity. A physio-
logic concentration of estradiol (109 mol/L) partly re- The specificity of our in-vitro CK2 activity assay was
tested further using an activator of CK2 activity (poly-versed FBS-stimulated CK2 activity. DRB, a selective CK2
inhibitor, also partly reversed the stimulatory effects of lysine) together with inhibitors of CK2 activity (heparin,
DRB) [8, 16]. In addition, the effect of staurosporineFBS. Heparin, a potent inhibitor of CK2 activity [7], com-
pletely reversed FBS-stimulated CK2 activity. TGF-1 was tested, which inhibits most protein kinases, but has
no effect on CK2. Polylysine stimulated CK2 activity(2 ng/mL, 4 h) markedly enhanced CK2 activity in cells
grown in serum-free, phenol red-free RPMI. The stimu- (Table 1F and Fig. 1D). This effect was reversed by DRB
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Fig. 1. (A) Transforming growth factor-1 (TGF-1, 2 ng/mL) increases casein kinase II (CK2)  protein at eight hours. This effect is reversed
by estradiol. A representative Western blot is shown. (B) Effect of the indicated agents on protein kinase CK2 activity in murine mesangial cells;
20% fetal bovine serum (FBS)-induced up-regulation of CK2 activity is reversed by anti-TGF-1 antibody, DRB (6 mol/L), estradiol (109 mol/L),
and heparin (10 g/mL). TGF-1 (2 ng/mL, 4 hours) also stimulates CK2 activity. The stimulatory effects of TGF-1 and serum are not additive.
TGF-1-stimulated CK2 activity is also reversed by estradiol and DRB. The inhibitory effect of estradiol is reversed by ICI 182,780 (108 mol/L).
(C) Time course of activation of protein kinase CK2 activity by TGF-1 (2 ng/mL) in murine mesangial cells. TGF-1 rapidly up-regulates CK2
activity within 10 minutes. Stimulation plateaus at approximately 8 hours and is sustained until 30 hours. (D) Effect of the indicated agents on
protein kinase CK2 activity in murine mesangial cells. Cold GTP (10 mol/L) competes with radiolabeled ATP for phosphorylation of the test
peptide. Alkaline phosphatase (0.5–1.5 units/ml) reverses TGF-1 up-regulation of CK2 activity in a dose-dependent manner. This effect is reversed
by sodium orthovanadate (0.1 mmol/L). Polylysine (10 g/mL)-stimulated CK2 activity is reversed by DRB and heparin, whereas staurosporine
has no effect on CK2 activity. (E) TGF-1 (2 ng/mL, 4 hours) enhanced binding of nuclear extracts to the type IV collagen gene promoter. This
effect was reversed by the specific CK2 inhibitor, DRB (6 mol/L) and by estradiol (109 mol/L). Preincubation of nuclear extracts with anti-Sp1
antibody eliminated the enhanced binding. *P 
 0.001 vs. serum-free, phenol red-free RPMI; P 
 0.001 vs. TGF-1. P 
 0.05 vs. TGF-1.
Abbreviations are: A, alkaline phosphatase; TGF, anti-TGF-1 neutralizing antibody; ATP, adenosine 5-triphosphate; CK2, protein kinase CK2;
DRB, 5,6-dichloro-1--D-ribofuranosylbenzimidazole; E, estradiol; Hep, heparin; GTP, unlabeled guanine triphosphate; IgG, immunoglobulin G;
poly L, polylysine; stauro, staurosporine; V, sodium orthovanadate.
and by heparin. In contrast, staurosporine had no effect the type IV collagen gene promoter (Fig. 1E). TGF-1-
on CK2 activity. enhanced binding was reversed by the selective CK2
inhibitor, DRB (6mol/L) and by estradiol (109 mol/L).
Electrophoretic mobility shift assay Pre-incubation of nuclear extracts with antibody to Sp1
eliminated TGF-1-stimulated binding, indicating thatNuclear extracts from cells grown in the presence of
TGF-1 (2 ng/mL, 4 hours) showed increased binding to TGF-1 enhances binding of Sp1 to the consensus Sp1
Zdunek et al: Casein kinase II, TGF-b1 and estradiol2102
Table 1. ContinuedTable 1. Casein kinase II activity as assessed by phosphorylation
of a specific test substrate (cpm)
E.
TGF-1 91,589	2,637aA.
TGF-1alkaline phosphatase 0.5 U/mL 38,401	3,628afSerum-free 13	3
TGF-1alkaline phosphatase 1 U/mL 12,300	2,212ae20% FBS 100,713	1,530a
TGF-1alkaline phosphates 1.5 u/mL 77	5e20% FBSanti-TGF-1 antibody 29,151	1,985ab
TGF-1alkaline phosphatase (1.5 U/mL)20% FBSnonspecific IgG 98,711	873a
sodium orthovanadate (0.1 mmol) 91,122	3,490a20% FBSestradiol 109 mol/L 38,364	1,608ab
TGF-1 sodium orthovanadate 0.1 mmol 91,122	3,490a20% FBSDRB 6 lmol/L 12,368	821ab
Serum-free RPMI sodium orthovanadate 57	420% FBSheparin 10 ng/mL 14	2b
Serum-free RPMIalkaline phosphataseTGF-1 2 ng/mL 100,364	3,278a
1.5 U/mL 55	12TGF-120% FBS 96,205	413a
Serum-free RPMI sodium orthovanadateTGF-1estradiol 38,364	1,608ab
(0.1 mmol)alkaline phosphataseTGF-1estradiol ICI 182,780 108 mol/L 93,824	2,156a
(1.5 U/mL) 40	3TGF-1DRB 10,084	292ab
F.Anti-TGF-1 antibody 15	2
Serum-free 67	21Non-specific IgG 17	3
Polylysine 10 lg/mL 94,899	5,069aEstradiol 14	4
PolylysineDRB 10,800	280agDRB 21	6
Polylysineheparin 53	10gHeparin 21	3
DRB 29	15ICI 182,780 42	4
Heparin 38	9B.
Staurosporine 1 lmol 49	16Serum-free 30	5
20% FBS 4 hours 84,465	3,252a Abbreviations are: cpm, counts per minute; FBS, fetal bovine serum; TGF-1,
20% FBScycloheximide 10 lg/mL; 4 hours 83,631	826a transforming growth factor-beta 1; IgG, immunoglobulin G; DRB, 5,6-dichloro-
20% FBSestradiol 109 mol/mL; 4 hours 28,451	1,760ac 1--D-ribofuranosylbenzimidazole.
a P 
 0.001 vs. serum-free20% FBSestradiolcycloheximide 4 hours 34,426	2,735ac
b P 
 0.001 vs. 20% FBS or vs. TGF-1TGF-1 4 hours 87,153	2,074a
c P 
 0.001 vs. FBS or vs. TGF-1TGF-1cycloheximide 4 hours 82,080	3,749a
d P
 0.001 vs. serum-free nuclear and vs. TGF-1 cytosol or 20% FBS cytosolTGF-1estradiol 4 hours 31,859	3,783ac
e P 
 0.001 vs. TGF-1TGF-1estradiolcycloheximide 4 hours 35,411	3,162ac f P 
 0.05 vs. TGF-1
Cycloheximide 4 hours 30	3 g P 
 0.001 vs. polylysine
Estradiol 4 hours 33	4
TGF-1 8 hours 71,131	4,847a
TGF-1cycloheximide 8 hours 1,860	14ac
Cycloheximide 8 hours 20	4
Estradiol 8 hours 44	5 effect on collagen IV gene transcription (103.9 	 2.0,
C. 102.3 	 3.8, 107.5 	 2.8, P  NS; data not shown).Serum-free RPMI-cytosol 30	1
Alkaline phosphatase reversed TGF-1–stimulated col-Serum-free RPMI-nucleus 36	6
TGF-1 (2 ng/mL, 4 hours)cytosol 39	6 lagen IV gene transcription in a dose-dependent manner
TGF-1nucleus 90,678	3,149d (0.5 U/mL alkaline phosphatase, 130.6 	 1.2, P  NS20% FBScytosol 38	7
20% FBSnucleus 68,078	4,138d vs. serum-free; 1.0 U/mL alkaline phosphatase, 117.5 	
D. 3.2, P  NS vs. serum-free; 1.5 U/mL alkaline phospha-
TGF-1 2 ng/mL, 4 hours 91,901	3,898
tase, 102.7 	 5.5, P 
 0.02 vs. TGF-1 alone, P  NSTGF-1cold GTP 10 lmol/L 10,221	1,112e
vs. serum-free). The effect of alkaline phosphatase on
TGF-1-stimulated collagen IV gene transcription was
reversed by sodium orthovanadate (157.5 	 0.6, P  NS
vs. TGF-1 alone, P 
 0.003 vs. serum-free). Neitherbinding site on the type IV collagen promoter (Fig. 1E).
alkaline phosphatase nor sodium orthovanadate aloneIdentical results were obtained using a consensus Sp1
had any effect on luciferase activity (102.2	 5.1, 104.5	binding site oligonucleotide (not shown).
3.6, P  NS; not shown).
Collagen IV gene transcription Polylysine stimulated collagen IV gene transcription
(152.7 	 3.6, P 
 0.008 vs. serum-free; Fig. 2A). ThisTransforming growth factor-1 stimulated collagen IV
effect was reversed by DRB, heparin and estradiolgene transcription as assessed by luciferase activity of our
(90.3 	 3.9, 98.7 	 2.4, 89.8 	 5.0, P  NS vs. serum-mini gene construct (151.4	 9.1, expressed as percent of
free). In contrast, staurosporine had no effect on collagenvalues obtained in cells grown in serum-free, phenol red-
IV gene transcription (111.0 	 3.8, P  NS vs. serum-free RPMI, P 
 0.01; Fig. 2A). The stimulatory effect
free).of TGF-1 was reversed by DRB (100.5 	 3.3, P 
 0.02
vs. TGF-1 alone, P  NS vs. serum-free), by heparin
Type IV collagen synthesis(94.2 	 6.8, P 
 0.001 vs. TGF-1 alone, P  NS vs.
Twenty percent FBS increased type IV collagen syn-serum-free) and by estradiol (109 mol/L; 102.3 	 5.4,
thesis as compared to mesangial cells grown in serum-P 
 0.0001 vs. TGF-1 alone, P  NS vs. serum-free).
Neither DRB, or heparin, nor estradiol alone had any free, phenol red-free RPMI (275 	 9; expressed as a
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Fig. 2. (A) Effect of the indicated agents on collagen IV gene transcription as assessed by luciferase activity of a mini gene construct. TGF-1-
stimulated type IV collagen gene transcription was reversed by DRB (6 mol/L), heparin (10 g/mL), estradiol (109 mol/L) and alkaline
phosphatase (0.5 to 1.5 /mL). The effect of alkaline phosphatase was reversed by sodium orthovanadate (0.1 mmol/L). Polylysine (10 g/mL)-
stimulated type IV collagen gene transcription was reversed by DRB, heparin and estradiol. Staurosporine (1 mol/L) had no effect on type IV
collagen gene transcription. (B) DRB (6 mol/L) reverses 20% FBS-stimulated and TGF-1 (2 ng/mL)–stimulated type IV collagen synthesis in
murine mesangial cells. A representative Western blot is shown. (C ) Alkaline phosphatase (0.5 U/mL) partially reverses TGF-1 (2 ng/mL)-
stimulated type IV collagen synthesis in murine mesangial cells. Sodium orthovanadate (0.1 mmol/L) counteracts the effect of alkaline phosphatase.
A representative Western blot is shown. (D) Densitometry readings of the Western blots (N  5) for type IV collagen depicted in panel C. *P 

0.01 vs. serum-free, phenol red-free RPMI; P 
 0.001 vs. TGF-1; P 
 0.02 vs. TGF-1; P 
 0.05 vs. TGF-1. Abbreviations are: A,
alkaline phosphatase; DRB, 5,6-dichloro-1--D-ribofuranosylbenzimidazole; E, estradiol; Hep, heparin; PolyL, polylysine; TGF or T, TGF-1; V,
sodium orthovanadate.
percent of serum-free values, P 
 0.001; Fig. 2B). FBS- (325 	 15, P  NS vs. TGF-1 alone). Neither alkaline
phosphatase alone, sodium orthovanadate alone nor thestimulated type IV collagen synthesis was reversed by
DRB (117 	 4, P 
 0.001 vs. 20% FBS). Similarly, combination had any effect on type IV collagen synthesis
(101 	 3, 94 	 5, 105 	 9, P  NS vs. serum-free).TGF-1-stimulated type IV collagen synthesis was re-
versed by DRB (443 	 9 vs. 121 	 8, P 
 0.001 vs.
Western blotting for Egr-1 and Sp1TGF-1 alone). DRB alone had no effect on type IV
collagen synthesis by mesangial cells grown in serum- Egr-1 protein levels in nuclear extracts of mesangial
cells grown in serum-free, phenol red-free RPMI werefree media (102 	 4, P  NS). Similar results were
obtained with heparin (not shown). not altered after four hours of exposure to either 20%
FBS (103 	 4, expressed as a percent of serum-freePolylysine also stimulated type IV collagen synthesis
(415 	 13, expressed as percent of serum-free values, values, P  NS), TGF-1 (2 ng/mL; 108 	 6, P  NS)
or estradiol (109 mol/L; 98 	 7, P  NS; Fig. 3A).P
 0.001 vs. serum-free; not shown). Staurosporine had
no effect on type IV collagen synthesis (92 	 4, P  NS; Similarly, Sp1 protein levels in nuclear extracts of mes-
angial cells grown in serum-free, phenol red-free RPMInot shown).
Transforming growth factor-1-stimulated type IV were not altered after four hours of exposure to 20%
FBS, TGF-1 (2 ng/mL), or estradiol (109 mol/L): 110	collagen synthesis was partially reversed by alkaline
phosphatase (0.5 U/mL; 380 	 22 vs. 184 	 19, P 
 6, 94 	 4, 105 	 6, respectively, P  NS; Fig. 3B).
Transforming growth factor-1 (2 ng) increased ser-0.05; Fig. 2 C, D). The effect of alkaline phosphatase
on TGF-1-stimulated type IV collagen synthesis was ine-phosphorylated Egr-1 in nuclear extracts from mes-
angial cells grown in serum-free, phenol red-free RPMIreversed by sodium orthovanadate (342 	 21, P  NS
vs. TGF-1 alone). Sodium orthovanadate alone had no in a time-dependent manner (Fig. 3C). Phospho Egr-1
was increased after four and six hours (4 hours, 298 	effect on TGF-1–stimulated type IV collagen synthesis
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Fig. 3. (A) Neither 20% FBS, TGF-1 (2 ng/
mL) nor estradiol (109 mol/L; 4 hours) have
any effect on Egr-1 protein levels in nuclear
extracts of murine mesangial cells. A represen-
tative Western blot for Egr-1 is shown. (B)
Neither 20% FBS, TGF-1 (2 ng/mL) nor es-
tradiol (109 mol/L; 4 hours) have any effect
on Sp1 protein levels in nuclear extracts of
murine mesangial cells. A representative West-
ern blot for Sp1 is shown. (C ) TGF-1 (2 ng/
mL) increases levels of serine-phosphorylated
Egr-1 in nuclear extracts of murine mesangial
cells in a time-dependent manner (upper panel).
The effect of TGF-1 is completely reversed
by estradiol (109 mol/L; lower panel). Egr-1
was first immunoprecipitated from nuclear ex-
tracts. The immunoprecipitate was then probed
by Western blotting using an antibody directed
against phosphoserine. A representative West-
ern blot is shown. (D) Twenty percent FBS (4
hours) increases levels of serine-phosphory-
lated Egr-1 in nuclear extracts of murine mes-
angial cells. The effect of 20% FBS is reversed
by estradiol in a time-dependent manner. Egr-
1 was first immunoprecipitated from nuclear
extracts. The immunoprecipitate was then
probed by Western blotting using an antibody
directed against phosphoserine. A representa-
tive Western blot is shown.
12, P 
 0.001 vs. serum-free RPMI; six hours, 364 	 mol/L, 4 hours) had no effect on the level of Egr-1/
Sp1 complexes isolated from cells grown in serum-free,18, P 
 0.001 vs. serum-free). Estradiol (109 mol/L)
completely reversed TGF-1-stimulated phosphoryla- phenol red-free RPMI (101 	 4, P  NS vs. serum-free
RPMI; not shown).tion of Egr-1 (110	 7 and 102	 5, P
 0.001 vs. TGF-1,
P  NS vs. serum free RPMI; Fig. 3C). Estradiol alone Egr-Sp1 complexes in nuclear extracts from mesangial
cells grown in serum-free, phenol red-free RPMI were(109 mol/L, 4 hours) had no effect on phospho Egr-1
levels (102 	 3, P  NS vs. serum-free RPMI; not markedly reduced by the addition of 20% FBS (4 hours;
11 	 3, expressed as a percent of values obtained inshown).
Serine-phosphorylated Egr-1 protein was increased in serum-free RPMI, P 
 0.001; Fig. 4B). The ability of
20% FBS to reduce the level of Egr-1/Sp1 complexes innuclear extracts of mesangial cells exposed to 20% FBS
for four hours as compared to cells grown in serum-free, mesangial cell nuclear extracts was reversed by exposure
to estradiol for four and six hours (4 hours, 380 	 12,phenol red-free RPMI (326 	 17, expressed as a percent
of serum-free values, P 
 0.001; Fig. 3D). Phosphoryl- expressed as a percent of cells grown in 20% FBS, P 

0.001; 6 hours, 290 	 17, P 
 0.001) but not by exposureated Egr-1 protein levels in nuclear extracts from mesan-
gial cells grown in 20% FBS were markedly reduced for one or two hours (1 hour, 110 	 4; 2 hours, 102 	
8, both P  NS; Fig. 4B).after exposure to estradiol (109 mol/L) for four and six
hours (4 hours, 15 	 4, expressed as a percent of values Identical results were obtained when Egr-1/Sp1 com-
plexes were first co-immunoprecipitated by Egr-1 anti-obtained in cells grown in 20% FBS, P
 0.001; six hours,
21	 7, P
 0.001) but not after one or two hours (1 hour, body and then probed with Sp1 antibody (data given
above) or when Egr-1/Sp1 complexes were first co-immu-104 	 3, P  NS; 2 hours, 97 	 7, P  NS; Fig. 3D).
Transforming growth factor-1 (2 ng/mL) markedly noprecipitated by Sp1 antibody and then probed with
Egr-1 antibody (data not shown).reduced Egr-1/Sp1 complexes in nuclear extracts from
mesangial cells in a time-dependent manner as compared Unbound Sp1, measured in the supernatant of mesan-
gial cell nuclear extracts after immunoprecipitation ofto cells grown in serum-free media (4 hours, 12 	 3,
expressed as a percent of serum-free RPMI, P
 0.001; 6 Egr-1/Sp1 complexes, was increased in nuclear extracts
from mesangial cells exposed to TGF-1 (2 ng/mL) inhours, 8	 2, P
 0.001 vs. serum-free; Fig. 4A). Estradiol
(109 mol/L) completely reversed the ability of TGF-1 a time-dependent manner (Fig. 4C). Unbound Sp1 was
increased by TGF-1 at four and six hours (4 hours,(2 ng/mL) to reduce Egr-1/Sp1 complexes at four and
six hours (109 	 6 and 102 	 4, P 
 0.001 vs. TGF-1, 360 	 11, expressed as a percent of serum-free RPMI,
P 
 0.001; 6 hours, 340 	 13, P 
 0.001). This effectP  NS vs. serum-free; Fig. 4A). Estradiol alone (109
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Fig. 4. (A) TGF-1 (2 ng/mL) reduces Egr-1/Sp1 complexes in nuclear extracts of murine mesangial cell in a time-dependent manner (upper
panel). The effect of TGF-1 is completely reversed by estradiol (109 mol/L; lower panel). Egr-1/Sp1 complexes were co-immunoprecipitated
from nuclear extracts with anti-Egr-1 antibody and then probed for Sp1 by Western blotting. A representative Western blot is shown. (B) Twenty
percent FBS (4 hours) reduces Egr-1/Sp1 complexes in nuclear extracts of murine mesangial cell. The effect of 20% FBS is reversed by estradiol
(109 mol/L) in a time-dependent manner. Egr-1/Sp1 complexes were co-immunoprecipitated from nuclear extracts by anti-Egr-1 antibody and
then probed for Sp1 by Western blotting. A representative Western blot is shown. (C ) TGF-1 (2 ng/mL) increases unbound Sp1 in mesangial
cell nuclear extracts in a time-dependent manner (upper panel). The effect of TGF-1 is completely reversed by estradiol (109 mol/L; lower
panel). Sp1 was immunoprecipitated from nuclear extracts. The immunoprecipitate underwent a second immunoprecipitation with anti-Egr-1
antibody. The resultant supernatant was probed for Sp1 by Western blotting. A representative Western blot is shown. (D) Estradiol (109 mol/L)
decreases unbound Sp1 in nuclear extracts of mesangial cells grown in 20% FBS at four and six hours. A representative Western blot is shown.
Abbreviations are: Egr-1, early growth response-1; TGF, TGF-1; E, estradiol; FBS, 20% fetal bovine serum.
was completely reversed by estradiol (109 mol/L; 102 	 factor (EGF), insulin and insulin-like growth factor-1
6 and 107 	 5, P 
 0.001 vs. TGF-1, P  NS vs. serum- (IGF-1) have been shown to stimulate CK2 activity
free; Fig. 4C). Unbound Sp1 was unchanged in nuclear [18–22]. By contrast, TGF-1 was found to have no effect
extracts from mesangial cells grown in serum-free media on CK2 activity in ML-1 human myeloblastic leukemia
after exposure to estradiol alone (109 mol/L, 4 hours; cells [17].
97 	 5, P  NS; not shown). We found that the basal activity of CK2 in total cellular
Unbound Sp1 in nuclear extracts from mesangial cells extracts of mesangial cells grown in serum-free media
grown in serum-free, phenol red-free RPMI was mark- was low and that 20% FBS markedly stimulated enzyme
edly increased by 20% FBS (4 hours; 455	 15, expressed activity. Anti-TGF-1 neutralizing antibody partly re-
as a percent of cells grown in serum-free, phenol red-free versed the effect of FBS, suggesting that TGF-1 medi-
RPMI, P 
 0.001; not shown). The ability of 20% FBS ates, in part, the stimulatory effect of FBS on CK2 activ-
to reduce the level of unbound Sp1 in mesangial cell nu- ity. Consistent with these findings, recombinant TGF-1
clear extracts was reversed by exposure to estradiol (109 markedly up-regulated CK2 activity. In contrast, estra-
mol/L) for four and six hours (4 hours, 6 	 2, expressed diol, in a physiologic concentration, reversed to a similar
as a percent of cells grown in 20% FBS alone; 6 hours, degree the effects of both FBS and TGF-1. The stimula-
9 	 3, both P 
 0.001), but not after exposure for one tory effects of TGF-1 and serum on CK2 activity were
and two hours (1 hour, 105 	 3.6; 2 hours, 113 	 8, both
due entirely to up-regulation of activity in the nuclearP  NS; Fig. 4D).
fraction. This observation differs from the finding of
other investigators that serum, EGF, IGF-1 and insulin
DISCUSSION stimulate cytosolic CK2 activity [8, 17–22]. However,
these other studies failed to exclude nuclear contamina-Casein kinase II activity is modulated by various cyto-
kines and hormones [8, 17–22]. Serum epidermal growth tion of their cytosolic preparations. Moreover, recent
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evidence clearly indicates that activation of CK2 is asso- cated on chromosome 13 in a head to head orientation
separated by a common bidirectional promoter regionciated with translocation of CK2 from the cytoplasm to
the nucleus [23, 24]. which contains two GC box binding sites for Sp1 [33].
Schmidt et al showed that mutation of the central GCOur study utilized a synthetic peptide that is a highly
specific substrate for CK2 to assess enzyme activity [12]. box in the collagen IV promoter reduced transcription
of a promoter/reporter gene construct suggesting thatA protein kinase that phosphorylates the low density
lipoprotein (LDL) receptor has recently been shown to binding of Sp1 to this motif is necessary for maximal
transcriptional activity [34]. Burbelo et al showed thatalso phosphorylate this test substrate [25]. However,
polylysine, which is known to activate CK2, inhibits the nuclear extracts from mouse Engelbreth-Holm-Swarm
tumor cells bind to the murine promoter at two regionsLDL receptor kinase [25]. Thus, activation by polylysine
in our study excludes the LDL receptor kinase as our that contain a novel CTC motif and a Sp1-like binding
site [35]. Neither of the two consensus Sp1 binding sitesTGF-1-activated enzyme. That we are measuring CK2
activity was further confirmed by showing that both was contained within the protected regions [35]. How-
ever, binding reactions were found to be cell type-specificDRB, a potent and specific inhibitor of CK2 [8, 16], and
heparin, another potent CK2 inhibitor [7], completely as protein/DNA complexes formed with nuclear extracts
from Engelbreth-Holm-Swarm cells showed different gelprevented phosphorylation of the synthetic substrate by
TGF-1 and by FBS. Highly specific for CK2 is the ability shift mobility than did nuclear extracts from differenti-
ated F9 cells [35].to use ATP or GTP as a phosphate donor [7]. Thus, the
ability of excess unlabeled GTP to quench phosphoryla- We have shown that the transcription factor Sp1 medi-
ates the stimulatory effect of TGF-1 on type IV collagention of the synthetic peptide with radiolabeled ATP fur-
ther confirms that we are measuring CK2 activity. How- gene transcription and protein synthesis and that physio-
logic concentrations of estradiol reverse these effects byever, we cannot exclude the possibility that TGF-1 is
stimulating a yet-unidentified kinase with properties in- interfering with TGF-1/Sp1 interactions [6]. We found
that nuclear extracts from mesangial cells grown in thedistinguishable from those of CK2.
Transforming growth factor- receptors II and V have presence of TGF-1 showed enhanced binding to Sp1
consensus binding site located in the bidirectional typecasein kinase activity and might be responsible for the
effects we have attributed to CK2 [26, 27]. However, IV collagen promoter, and that this effect was reversed
by physiologic concentrations of estradiol [6].the casein kinase activity of TGF- receptor II is not
stimulated by TGF- nor is it inhibited by heparin [26]. Srivastava et al described a novel interaction between
estrogen, Egr-1 and Sp1 that is dependent on CK2 activ-These characteristics differentiate type II receptor casein
kinase activity from the TGF--stimulated and heparin- ity [9]. In murine bone marrow stromal cells, estrogen
blocks macrophage colony-stimulating factor (M-CSF)inhibitable CK activity reported in our current study. In
contrast, the activator and inhibitor profile of TGF- expression via inhibition of CK2 activity [9]. These inves-
tigators showed that CK2 phosphorylates Egr-1, whichreceptor V casein kinase activity is similar to that of
CK2 [27, 28]. However, the motif recognized by TGF- inhibits its binding to Sp1; this leads to increased un-
bound Sp1, which in turn activates M-CSF gene tran-receptor V differs from that recognized by CK2. As such,
the specific substrate utilized in our studies distinguishes scription [9]. Estrogen inhibits the phosphorylation of
Egr-1 by CK2 leading to increased binding of Sp1 tothese two casein kinase activities. Moreover, the stimula-
tory effect of TGF- on TGF- receptor V casein kinase Egr-1, which in turn reduces the amount of unbound
Sp1 available to transactivate the M-CSF gene [9].activity is quite modest, contrasting with the marked
activation observed in our studies [27]. Our data show that TGF-1 stimulates CK2 activity
in murine mesangial cells within ten minutes, precludingEgr-1 protein is a transcription factor whose transacti-
vation activity is regulated by its state of phosphorylation a role for new protein synthesis in this early activation.
Consistent with this observation, up-regulation of CK2and which induces genes involved in cell proliferation
and differentiation [29]. The Egr-1 promoter contains activity by TGF-1 was not inhibited by cycloheximide
at four hours. In contrast, sustained up-regulation ofa half palindromic estrogen response element in its 5
flanking region [30]. Estradiol up-regulates Egr-1 synthe- CK2 activity by TGF-1 at eight hours was dependent
on new protein synthesis. This observation is consistentsis at a transcriptional level in a variety of cell types and
tissues [30–32]. In contrast, estrogen was shown to reduce with our finding that TGF-1 increases CK2  protein
at eight hours.the level of Egr-1 detected in nuclear extracts of murine
bone marrow stromal cells from ovariectomized mice [9]. Activation of CK2 by TGF-1 is dependent on a phos-
phorylation step. Activation was blocked by alkalineIn keeping with these data indicating cell type-specific
responses, we did not detect any effect of estradiol on phosphatase in the absence of, but not in the presence
of sodium orthovanadate, a phosphatase inhibitor. Al-total Egr-1 levels in mesangial cell nuclear extracts.
The murine 1 and 2 type IV collagen genes are lo- though TGF-1 failed to alter total Egr-1 protein, it
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the progression of non-diabetic renal disease: A meta-analysis.increased CK2-mediated phosphorylation of Egr-1. This
J Am Soc Nephrol 11:319–329, 2000
led to decreased Egr-1/Sp1 complex formation, increased 4. Kwan G, Neugarten J, Sherman M, et al: Effects of sex hormones
on mesangial cell proliferation and collagen synthesis. Kidney Intunbound Sp1, increased binding of nuclear extracts to a
50:1173–1179, 1996Sp1 consensus binding sequence oligonucleotide, and
5. Lei J, Silbiger S, Ziyadeh FN, et al: Serum-stimulated 1 type IVincreased type IV collagen gene transcription and pro- collagen gene transcription is mediated by TGF- and inhibited
by estradiol. Am J Physiol 274:F252–F258, 1998tein synthesis. Physiologic concentrations of estradiol
6. Silbiger S, Lei J, Ziyadeh FN, et al: Estradiol reverses TGF-1-reversed the TGF-1-stimulated CK2 activity and all
stimulated type IV collagen gene transcription in murine mesangial
these subsequent events. cells. Am J Physiol 43:F1113–F1118, 1998
7. Allende JE, Allende CC: Protein kinase CK2: An enzyme withOur data in murine mesangial cells and those of Srivas-
multiple substrates and a puzzling regulation. FASEB J 9:313–323,tava et al in murine bone marrow stromal cells [9] differ 1995
from those reported by several other investigators. Cas- 8. Guerra B, Boldyreff B, Sarno S, et al: CK2: A protein kinase
in need of control. Pharmacol Ther 82:303–313, 1999tano, Vorojeikina and Notides showed that phosphoryla-
9. Srivastava S, Weitzmann MN, Kimble RB, et al: Estrogen blockstion of the estrogen receptor by CK2 is enhanced by M-CSF gene expression and osteoclast formation by regulating
estradiol [36]. Cieslik et al showed that in spontaneously phosphorylation of Egr-1 and its interaction with Sp1. J Clin Invest
102:1850–1859, 1998transformed human umbilical vein endothelial cells, CK2
10. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates
phosphorylates and inactivates protein phosphatase 2A the proliferation and biosynthesis of type I collagen in cultured
murine mesangial cells. Am J Pathol 140:95–107, 1992leading to reduced dephosphorylation of Sp1 and re-
11. Heller-Harrison RA, Czech MP: Enhanced casein kinase IIduced DNA binding activity [16]. Mueller and coworkers
activity in COS-1 cells upon overexpression of either its catalytic
found that in rat liver, CK2 directly phosphorylates Sp1, or noncatalytic subunit. J Biol Chem 266:14435–14439, 1991
12. Kuenzel EA, Krebs EG: A synthetic peptide substrate specificreducing its DNA binding activity by approximately ten-
for casein kinase II. Proc Natl Acad Sci USA 82:737–741, 1985fold [37, 38]. In contrast, our gel shift data clearly indicate
13. Satriano J, Schlondorff D: Activation and attenuation of tran-
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response to tumor necrosis factor-, immunoglobulin  and adeno-to DNA insofar as this enhanced binding is reversed by
sine 3:5-cyclic monophosphate. Evidence for involvement of reac-a specific CK2 inhibitor, DRB. It is difficult to reconcile tive oxygen species. J Clin Invest 94:1629–1636, 1994
these differing effects of CK2 on the DNA binding activ- 14. Fumo P, Kuncio GS, Ziyadeh FN: PKC and high glucose stimulate
collagen 1(IV) transcriptional activity in a reporter mesangial cellity of Sp1 in different cell types. Perhaps differences
line. Am J Physiol 267:F632–F638, 1994are related to cell type-specific transcription cofactors 15. Ausubel F, Brent R, Kingston R, et al: Introduction of DNA
or inhibitors. into mammalian cells, in Current Protocols in Molecular Biology,
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